Legalize / European Union / Implementing Regulation

Commission Implementing Regulation (EU) 2025/1846 of 11 September 2025 cancelling the Union authorisation for the single biocidal product Nordkalk QL 0-0,1 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council and repealing Commission Implementing Regulation (EU) 2024/1478

Type Implementing Regulation

Publication 2025-09-12

State In force

Text As published

Department European Commission, SANTE

Source EUR-Lex

articles 4

This is the act as published. Later amendments are not folded into the text below: each one is a separate act in this repository and an entry in this law's history.

Reform history JSON API


Image omitted; see official source	Official Journal of the European Union	EN L series

---	---	---
	2025/1846	12.9.2025

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products [^ntr1-L_202501846EN.000101-E0001], and in particular Article 49 thereof,

Whereas:

(1) On 29 May 2024, Commission Implementing Regulation (EU) 2024/1478 [^ntr2-L_202501846EN.000101-E0002] granted a Union authorisation with the authorisation number EU-0029359-0000 to the authorisation holder Nordkalk AB for the making available on the market and use of the same single biocidal product ‘Nordkalk QL 0-0,1’ in accordance with Article 44(5), first subparagraph, of Regulation (EU) No 528/2012.

(2) On 15 May 2025, Nordkalk AB submitted a request to cancel that Union authorisation to the European Chemicals Agency (‘the Agency’) in accordance with Article 49 of Regulation (EU) No 528/2012. The request was recorded under case number BC-MD105909-40 in the Register for Biocidal Products.

(3) On 28 May 2025, Nordkalk AB submitted a reasoning for the request for cancellation, providing that it had decided to discontinue the production of ‘Nordkalk QL 0-0,1’ based on commercial considerations.

(4) On 3 June 2025, the Agency forwarded the request to the Commission.

(5) It is therefore appropriate to cancel the Union authorisation for the single biocidal product ‘Nordkalk QL 0-0,1’ at the request of the authorisation holder and consequently to repeal Implementing Regulation (EU) 2024/1478.

(6) It is also appropriate to grant a period of grace for the making available on the market and the use of the existing stocks in accordance with Article 52 of Regulation (EU) No 528/2012,

HAS ADOPTED THIS REGULATION:

Article 1

The Union authorisation for the single biocidal product ‘Nordkalk QL 0-0,1’ granted by Implementing Regulation (EU) 2024/1478 to Nordkalk AB with the authorisation number EU-0029359-0000 is cancelled.

Article 2

Implementing Regulation (EU) 2024/1478 is repealed.

Article 3

The biocidal product ‘Nordkalk QL 0-0,1’ shall no longer be made available on the market from 31 March 2026 and existing stocks of such biocidal product shall no longer be used from 27 September 2026.

Article 4

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 11 September 2025.

For the Commission

The President

Ursula VON DER LEYEN

[^ntr1-L_202501846EN.000101-E0001]: OJ L 167, 27.6.2012, p. 1, ELI: http://data.europa.eu/eli/reg/2012/528/oj.

[^ntr2-L_202501846EN.000101-E0002]: Commission Implementing Regulation (EU) 2024/1478 of 29 May 2024 granting a Union authorisation for the single biocidal product ‘Nordkalk QL 0-0,1’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L, 2024/1478, 30.5.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/1478/oj).

ELI: http://data.europa.eu/eli/reg_impl/2025/1846/oj

ISSN 1977-0677 (electronic edition)

Reading this document does not replace reading the official text published in the Official Journal of the European Union. We assume no responsibility for any inaccuracies arising from the conversion of the original to this format.

This text is published under EUR-Lex's own terms of reuse, not a Legalize or public-domain licence. EUR-Lex
Creative Commons Attribution 4.0 International (CC BY 4.0)
© European Union, https://eur-lex.europa.eu — Source: EUR-Lex (Publications Office of the European Union). Reused under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence. Only EU legislation published in the printed Official Journal of the European Union is deemed authentic; consolidated texts are reproduced here for documentation purposes and have been reformatted to Markdown.